Drug Resistance

  • Your Selections:

Refine Results

date

Tags

More Action Needed To Address Antimicrobial Resistance, Lancet Editorial Says

The Lancet: The antimicrobial crisis: enough advocacy, more action Editorial Board “…Addressing [antimicrobial resistance (AMR)] is a complex issue. The formal tripartite of WHO, the Food and Agriculture Organization, and the World Organisation for Animal Health must have a major role in identifying and promoting the implementation of feasible strategies…

Pharma Industry Expert Discusses Efforts To Address AMR In Europe

Euractiv: Fighting antimicrobial resistance requires action on many fronts Koen Laenen, regulatory affairs and quality manager at Medicines for Europe, discusses antimicrobial resistance and the steps European entities and the AMR Industry Alliance are taking to address the issue (1/22).

More News In Global Health

BBC: Zimbabwe doctors end strike after billionaire’s offer (1/22). CIDRAP News: WHO calls antibiotic pipeline insufficient (Dall, 1/22). Devex: In Nigeria, there is no quick fix for antibiotic abuse (Adepoju, 1/23). The Guardian: Millions at risk after toxins found in Harare water supply, study finds (Chingono, 1/22). New York Times:…

Lack Of New Drug Development, Antibiotic Access Gaps In Poorer Nations Hinder Efforts Against Antimicrobial Resistance, Annual Report Says

The Guardian: Lack of antibiotics in low-income countries ‘worsening superbugs threat’ “Many antibiotics are unavailable in poorer countries despite higher infection rates, exacerbating the threat of drug-resistant superbugs, according to a report to be presented to world leaders and the bosses of top pharmaceutical companies in Davos. The report, released…

Declining Private Investment, Lack Of Innovation In New Antibiotic Research Threaten Efforts To Prevent Drug-Resistant Infections, WHO Says

U.N. News: Urgent need for ‘immediate’ solutions to combat drug-resistant infections, warns WHO “Drug-resistant infections are on the rise as private investment in new antibiotic development declines, the World Health Organization (WHO) said on Friday. Two new WHO reports reveal that while some 50 new antibiotics and 10 biologics are…

3-Pronged Approach Needed To Increase Access To Antibiotics, AMR Industry Alliance Board Member Writes In Opinion Piece

Devex: Opinion: How to oppose the menace of antimicrobial resistance Serufusa Sekidde, board member of the AMR Industry Alliance “…5.7 million people, including 1 million children, are dying annually from antibiotic-treatable conditions because they cannot access the necessary antibiotics in time. … To increase access to antibiotics …, we need…

WHO Reports Highlight Declining Private Investment, Lack Of Innovation In New Antibiotic Research

WHO: Lack of new antibiotics threatens global efforts to contain drug-resistant infections “Declining private investment and lack of innovation in the development of new antibiotics are undermining efforts to combat drug-resistant infections, says the World Health Organization (WHO). Two new reports reveal a weak pipeline for antibiotic agents. … The…

More Opinions In Global Health

Devex: Opinion: Improving health outcomes in Papua New Guinea Amy Gildea, managing director of international development, Asia Pacific for Coffey (1/15). Devex: Opinion: Advances in AI and satellites can help us meet the SDGs Rhiannan Price, director of the sustainable development practice at Maxar (1/16). Forbes: Tokyo, 15 Others: Newest…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.